Correlation Between Faron Pharmaceuticals and SoftBank Group

Can any of the company-specific risk be diversified away by investing in both Faron Pharmaceuticals and SoftBank Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Faron Pharmaceuticals and SoftBank Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Faron Pharmaceuticals Oy and SoftBank Group Corp, you can compare the effects of market volatilities on Faron Pharmaceuticals and SoftBank Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Faron Pharmaceuticals with a short position of SoftBank Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Faron Pharmaceuticals and SoftBank Group.

Diversification Opportunities for Faron Pharmaceuticals and SoftBank Group

-0.77

Correlation Coefficient

Faron Pharmaceuticals  SoftBank Group

Pay attention - limited upside

The 3 months correlation between Faron and SoftBank is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Faron Pharmaceuticals Oy and SoftBank Group Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SoftBank Group Corp and Faron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Faron Pharmaceuticals Oy are associated (or correlated) with SoftBank Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SoftBank Group Corp has no effect on the direction of Faron Pharmaceuticals i.e., Faron Pharmaceuticals and SoftBank Group go up and down completely randomly.

Pair Corralation between Faron Pharmaceuticals and SoftBank Group

Assuming the 90 days trading horizon Faron Pharmaceuticals is expected to generate 1892.0 times less return on investment than SoftBank Group. In addition to that, Faron Pharmaceuticals is 2.01 times more volatile than SoftBank Group Corp. It trades about 0.0 of its total potential returns per unit of risk. SoftBank Group Corp is currently generating about 0.06 per unit of volatility. If you would invest  629,343  in SoftBank Group Corp on September 26, 2024 and sell it today you would earn a total of  259,058  from holding SoftBank Group Corp or generate 41.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	77.07%
Values	Daily Returns

Faron Pharmaceuticals Oy  vs.  SoftBank Group Corp

Faron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Faron Pharmaceuticals Oy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

SoftBank Group Corp

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in SoftBank Group Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, SoftBank Group is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Faron Pharmaceuticals and SoftBank Group

The main advantage of trading using opposite Faron Pharmaceuticals and SoftBank Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Faron Pharmaceuticals position performs unexpectedly, SoftBank Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SoftBank Group will offset losses from the drop in SoftBank Group's long position.

The idea behind Faron Pharmaceuticals Oy and SoftBank Group Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.